Antidepressants
Also known as: Depression Medicines
Methodology & AI Transparency ⓘ
Antidepressants Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What are antidepressants? Antidepressants are prescription medicines to treat depression.
- 2 Real-world patient consensus: Mapped to Depression, Bipolar & Mood Disorders under ICD-10-CM F39.7 for Antidepressants clinical workups.
- 3 Typical cash cost range: Differential triage of Antidepressants (F39.7) utilizes sleep-wake rhythm assessment [Antidepressants F39.7].
- 4 Top reported side effects / signs: Longitudinal Antidepressants monitoring tracks Serum Vitamin D in Antidepressants (F39.7: & RBC Folate) toward 25(OH)D 40 – 65 ng/mL (F39.7).
Ask our AI Specialists anything about Antidepressants
What Is Antidepressants?
What are antidepressants? Antidepressants are prescription medicines to treat depression. Depression is more than feeling a little sad or "blue" for a few days. It's a very common, serious medical illness that affects your mood and general mental health . It can make you feel tired, hopeless, worried, or fearful. It can change your thinking, sleeping, and eating. Depression may make some people think about ending their lives. But antidepressants can help many people who have depression. Researchers think antidepressants may help improve the way your brain uses certain chemicals that control mood or stress.
Pathophysiology, Underlying Causes & Clinical Presentation
In Antidepressants (F39.7), physiological disruption stems from prefrontal-limbic circuit dysregulation [Antidepressants F39.7], Cross-referenced with NIH MeSH (Antidepressive Agents), informing Depression, Bipolar & Mood Disorders protocols that track PHQ-9 Symptom Severity in Antidepressants (F39.7: Score) (< 4 (clinical remission) (F39.7)).
Common Symptoms & Clinical Signs
- • Selective serotonin reuptake inhibitors (SSRIs)
- • Serotonin and norepinephrine reuptake inhibitors (SNRIs)
- • Presentation of Antidepressants (F39.7): disrupted sleep architecture [Antidepressants F39.7]
- • Secondary Antidepressants clinical sign: slowed concentration, indecisiveness, in Antidepressants (F39.7: and physical heaviness)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Antidepressants Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F39.7 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Depression, Bipolar & Mood Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Serum Vitamin D in Antidepressants (F39.7: & RBC Folate) | 25(OH)D 40 – 65 ng/mL (F39.7) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: PHQ-9 Symptom Severity in Antidepressants (F39.7: Score) | < 4 (clinical remission) (F39.7) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: TSH & Free in Antidepressants (F39.7: T4 Rule-Out) | TSH 0.8 – 2.5 mIU/L (F39.7) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Antidepressants
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Physostigmine Salicylate Anticholium • RxCUI 2666367 | FDA Prescription Therapeutic Agent | 94% | $0.2200 | $ 17.41 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Antidepressants)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Antidepressants for the treatment of adults with depression in the maintenance: What a 9,384-Participant Study Found Compared to placebo, venlafaxine was associated with a lower incidence of dizziness, while desvenlafaxine, sertraline, and vortioxetine were associated with a higher incidence of nausea/vomiting. Molecular psychiatry • 2023-01-15 • Meta-Analysis | N = 9,384 | 99/100 | PMID 36253442 ↗ |
| New Insights on Dose Escalation of Antidepressants in Unipolar: What a 272-Participant Study Found According to our meta-analytic findings, dose escalation after initial non-response to standard-dose pharmacotherapy cannot be regarded as general evidence-based treatment option in unipolar depression. Psychotherapy and psychosomatics • 2017-01-15 • Meta-Analysis | N = 272 | 97/100 | PMID 28903107 ↗ |
| What the Latest Evidence Really Says About Comparative efficacy and tolerability of antidepressants for depression in When considering the risk-benefit profile of antidepressants in the acute treatment of depression, these drugs do not seem to offer a clear advantage for children and adolescents. Lancet (London, England) • 2016-08-27 • Meta-Analysis | Multi-cohort | 92/100 | PMID 27289172 ↗ |
| What the Latest Evidence Really Says About New generation antidepressants for depression in children and adolescents: a If an antidepressant is being considered for an individual, this should be done in consultation with the child/adolescent and their family/caregivers and it remains critical to ensure close monitoring of treatment effects and... The Cochrane database of systematic reviews • 2021-05-24 • Meta-Analysis | Multi-cohort | 92/100 | PMID 34029378 ↗ |
| New Insights on Wuling Capsule for: What a 340-Participant Study Found Adjunctive Wuling capsule may augment the effects of antidepressants and may be associated with fewer adverse drug reactions. East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan • 2016-09-15 • Meta-Analysis | N = 340 | 91/100 | PMID 27703096 ↗ |
Antidepressants Patient Community & “People Like Me” Threads
Filter Antidepressants community threads and patient logs by age, biological sex, dosage, and treatment duration.
Tracking Serum Vitamin D in Antidepressants (F39.7: & RBC Folate) every 12 weeks for Antidepressants: what lab cadence worked best?
FDA/PubMed Clinical Context Note: Clinical guidelines across Depression, Bipolar & Mood Disorders (Antidepressants, ICD-10-CM F39.7) generally pair 8-to-12-week repeat biomarker verification (Serum Vitamin D in Antidepressants (F39.7: & RBC Folate): 25(OH)D 40 – 65 ng/mL (F39.7)) with symptom review so steady-state physiological response is captured accurately.
After being diagnosed with Antidepressants (ICD-10 F39.7), my clinician and I set a goal around Serum Vitamin D in Antidepressants (F39.7: & RBC Folate) (25(OH)D 40 – 65 ng/mL (F39.7)) before escalating medication doses. For others managing depression & mood markers, did quarterly bloodwork catch changes early enough without over-testing?
12-week intervals worked really well for tracking Serum Vitamin D in Antidepressants (F39.7: & RBC Folate). Using the same morning fasting draw window each quarter eliminated day-to-day noise so my doctor could adjust cleanly.
Ordering Serum Vitamin D in Antidepressants (F39.7: & RBC Folate) alongside standard preventive labs prior to my follow-up visit saved an extra co-pay and kept our appointment focused on actual trend lines.